Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19

{ 'indexed': {'date-parts': [[2022, 8, 10]], 'date-time': '2022-08-10T04:18:34Z', 'timestamp': 1660105114906}, 'reference-count': 38, 'publisher': 'Springer Science and Business Media LLC', 'license': [ { 'start': { 'date-parts': [[2022, 8, 9]], 'date-time': '2022-08-09T00:00:00Z', 'timestamp': 1660003200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2022, 8, 9]], 'date-time': '2022-08-09T00:00:00Z', 'timestamp': 1660003200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1007/s10654-022-00891-4', 'type': 'journal-article', 'created': {'date-parts': [[2022, 8, 9]], 'date-time': '2022-08-09T08:02:38Z', 'timestamp': 1660032158000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the ' 'prevention of COVID-19', 'prefix': '10.1007', 'author': [ {'given': 'Xabier', 'family': 'García-Albéniz', 'sequence': 'first', 'affiliation': []}, {'given': 'Julia', 'family': 'del Amo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rosa', 'family': 'Polo', 'sequence': 'additional', 'affiliation': []}, { 'given': 'José Miguel', 'family': 'Morales-Asencio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Miguel A', 'family': 'Hernán', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2022, 8, 9]]}, 'reference': [ { 'key': '891_CR1', 'unstructured': 'Pan H, Peto R, Karim QA, Alejandria M, Henao-Restrepo AM, García CH, et ' 'al. Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY ' 'trial results. medRxiv. 2020:2020.10.15.20209817.'}, { 'issue': '21', 'key': '891_CR2', 'doi-asserted-by': 'publisher', 'first-page': '2030', 'DOI': '10.1056/NEJMoa2022926', 'volume': '383', 'author': 'P Horby', 'year': '2020', 'unstructured': 'Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, et al. ' 'Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N ' 'Engl J Med. 2020;383(21):2030–40.', 'journal-title': 'N Engl J Med'}, { 'key': '891_CR3', 'doi-asserted-by': 'crossref', 'unstructured': 'Bienvenu AL, Marty AM, Jones MK, Picot S. Systematic review of ' 'registered trials of Hydroxychloroquine prophylaxis for COVID-19 ' 'health-care workers at the first third of 2020. One health (Amsterdam, ' 'Netherlands). 2020;10:100141.', 'DOI': '10.1016/j.onehlt.2020.100141'}, { 'issue': '6', 'key': '891_CR4', 'doi-asserted-by': 'publisher', 'first-page': '517', 'DOI': '10.1056/NEJMoa2016638', 'volume': '383', 'author': 'DR Boulware', 'year': '2020', 'unstructured': 'Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor ' 'EC, et al. A Randomized Trial of Hydroxychloroquine as Postexposure ' 'Prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517–25.', 'journal-title': 'N Engl J Med'}, { 'key': '891_CR5', 'unstructured': 'Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, et al. A ' 'Cluster-Randomized Trial of Hydroxychloroquine for Prevention of ' 'Covid-19. New England Journal of Medicine; 2020.'}, { 'issue': '11', 'key': '891_CR6', 'doi-asserted-by': 'publisher', 'first-page': 'e844-e7', 'DOI': '10.1093/cid/ciaa1707', 'volume': '72', 'author': 'JD Goldman', 'year': '2021', 'unstructured': 'Goldman JD. Hydroxychloroquine for Prevention of Severe Acute ' 'Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to ' 'Trial Conduct During the Global Pandemic. Clin Infect diseases: official ' 'publication Infect Dis Soc Am. 2021;72(11):e844-e7.', 'journal-title': 'Clin Infect diseases: official publication Infect Dis Soc Am'}, { 'key': '891_CR7', 'doi-asserted-by': 'crossref', 'unstructured': 'García-Albéniz X, Amo Jd, Polo R, Morales-Asencio JM, Hernán MA. ' 'Systematic review and meta-analysis of randomized trials of ' 'hydroxychloroquine for the prevention of COVID-19. medRxiv. ' '2022:2020.09.29.20203869.', 'DOI': '10.1101/2020.09.29.20203869'}, { 'key': '891_CR8', 'doi-asserted-by': 'publisher', 'first-page': 'l4898', 'DOI': '10.1136/bmj.l4898', 'volume': '366', 'author': 'JAC Sterne', 'year': '2019', 'unstructured': 'Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et ' 'al. RoB 2: a revised tool for assessing risk of bias in randomised ' 'trials. BMJ. 2019;366:l4898.', 'journal-title': 'BMJ'}, { 'issue': '3', 'key': '891_CR9', 'doi-asserted-by': 'publisher', 'first-page': '177', 'DOI': '10.1016/0197-2456(86)90046-2', 'volume': '7', 'author': 'R DerSimonian', 'year': '1986', 'unstructured': 'DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin ' 'Trials. 1986;7(3):177–88.', 'journal-title': 'Control Clin Trials'}, { 'issue': '24', 'key': '891_CR10', 'doi-asserted-by': 'publisher', 'first-page': '3875', 'DOI': '10.1002/sim.1009', 'volume': '20', 'author': 'J Hartung', 'year': '2001', 'unstructured': 'Hartung J, Knapp G. A refined method for the meta-analysis of controlled ' 'clinical trials with binary outcome. Stat Med. 2001;20(24):3875–89.', 'journal-title': 'Stat Med'}, { 'issue': '1', 'key': '891_CR11', 'doi-asserted-by': 'publisher', 'first-page': '25', 'DOI': '10.1186/1471-2288-14-25', 'volume': '14', 'author': 'J IntHout', 'year': '2014', 'unstructured': 'IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman ' 'method for random effects meta-analysis is straightforward and ' 'considerably outperforms the standard DerSimonian-Laird method. BMC Med ' 'Res Methodol. 2014;14(1):25.', 'journal-title': 'BMC Med Res Methodol'}, { 'issue': '15', 'key': '891_CR12', 'doi-asserted-by': 'publisher', 'first-page': '2503', 'DOI': '10.1002/sim.6879', 'volume': '35', 'author': 'A Wiksten', 'year': '2016', 'unstructured': 'Wiksten A, Rücker G, Schwarzer G. Hartung-Knapp method is not always ' 'conservative compared with fixed-effect meta-analysis. Stat Med. ' '2016;35(15):2503–15.', 'journal-title': 'Stat Med'}, { 'issue': '25', 'key': '891_CR13', 'doi-asserted-by': 'publisher', 'first-page': '3923', 'DOI': '10.1002/sim.7411', 'volume': '36', 'author': 'D Jackson', 'year': '2017', 'unstructured': 'Jackson D, Law M, Rücker G, Schwarzer G. The Hartung-Knapp modification ' 'for random-effects meta-analysis: A useful refinement but are there any ' 'residual concerns? Stat Med. 2017;36(25):3923–34.', 'journal-title': 'Stat Med'}, { 'issue': '1', 'key': '891_CR14', 'doi-asserted-by': 'publisher', 'first-page': '99', 'DOI': '10.1186/s12874-015-0091-1', 'volume': '15', 'author': 'C Röver', 'year': '2015', 'unstructured': 'Röver C, Knapp G, Friede T. Hartung-Knapp-Sidik-Jonkman approach and its ' 'modification for random-effects meta-analysis with few studies. BMC Med ' 'Res Methodol. 2015;15(1):99.', 'journal-title': 'BMC Med Res Methodol'}, { 'issue': '2', 'key': '891_CR15', 'doi-asserted-by': 'publisher', 'first-page': '301', 'DOI': '10.1002/sim.7140', 'volume': '36', 'author': 'C Partlett', 'year': '2017', 'unstructured': 'Partlett C, Riley RD. Random effects meta-analysis: Coverage performance ' 'of 95% confidence and prediction intervals following REML estimation. ' 'Stat Med. 2017;36(2):301–17.', 'journal-title': 'Stat Med'}, { 'issue': '1', 'key': '891_CR16', 'doi-asserted-by': 'publisher', 'first-page': '137', 'DOI': '10.1111/j.1467-985X.2008.00552.x', 'volume': '172', 'author': 'JP Higgins', 'year': '2009', 'unstructured': 'Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of ' 'random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. ' '2009;172(1):137–59.', 'journal-title': 'J R Stat Soc Ser A Stat Soc'}, { 'issue': '1', 'key': '891_CR17', 'doi-asserted-by': 'publisher', 'first-page': '808', 'DOI': '10.1186/s13063-021-05758-9', 'volume': '22', 'author': 'B Grau-Pujol', 'year': '2021', 'unstructured': 'Grau-Pujol B, Camprubí-Ferrer D, Marti-Soler H, Fernández-Pardos M, ' 'Carreras-Abad C, Andrés MV-d, et al. Pre-exposure prophylaxis with ' 'hydroxychloroquine for COVID-19: a double-blind, placebo-controlled ' 'randomized clinical trial. Trials. 2021;22(1):808.', 'journal-title': 'Trials'}, { 'key': '891_CR18', 'doi-asserted-by': 'crossref', 'unstructured': 'Liu HH, Ezekowitz MD, Columbo M, Khan O, Martin J, Spahr J, et al. ' 'Testing the feasibility of operationalizing a prospective, randomized ' 'trial with remote cardiac safety EKG monitoring during a pandemic. J ' 'Interv Card Electrophysiol. 2021:1–12.', 'DOI': '10.1007/s10840-021-00989-x'}, { 'key': '891_CR19', 'volume-title': 'Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in ' 'healthcare workers: a randomized trial', 'author': 'R Rajasingham', 'year': '2020', 'unstructured': 'Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ' 'ML, et al. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 ' 'in healthcare workers: a randomized trial. Clinical infectious diseases: ' 'an official publication of the Infectious Diseases Society of America; ' '2020.'}, { 'key': '891_CR20', 'doi-asserted-by': 'crossref', 'unstructured': 'Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, et al. ' 'Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure ' 'SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical ' 'Trial. JAMA internal medicine; 2020.', 'DOI': '10.1001/jamainternmed.2020.6319'}, { 'key': '891_CR21', 'doi-asserted-by': 'publisher', 'first-page': '314', 'DOI': '10.1016/j.ijid.2021.04.035', 'volume': '106', 'author': 'RCS Seet', 'year': '2021', 'unstructured': 'Seet RCS, Quek AML, Ooi DSQ, Sengupta S, Lakshminarasappa SR, Koo CY, et ' 'al. Positive impact of oral hydroxychloroquine and povidone-iodine ' 'throat spray for COVID-19 prophylaxis: An open-label randomized trial. ' 'Int J Infect Dis. 2021;106:314–22.', 'journal-title': 'Int J Infect Dis'}, { 'key': '891_CR22', 'doi-asserted-by': 'crossref', 'unstructured': 'Syed F, Arif MA, Niazi R, Baqar JB, Hashmi UL, Batool S, et al. ' 'Pre-Exposure Prophylaxis with Various Doses of Hdroxychloroquine among ' 'high-risk COVID 19 Healthcare Personnel: CHEER randomized controlled ' 'trial. medRxiv. 2021:2021.05.17.21257012.', 'DOI': '10.1101/2021.05.17.21257012'}, { 'key': '891_CR23', 'doi-asserted-by': 'crossref', 'unstructured': 'Naggie S, Milstone A, Castro M, Collins SP, Seetha L, Anderson DJ, et ' 'al. Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in ' 'health care workers: a randomized, multicenter, placebo-controlled trial ' '(HERO-HCQ). medRxiv. 2021:2021.08.19.21262275.', 'DOI': '10.1101/2021.08.19.21262275'}, { 'key': '891_CR24', 'doi-asserted-by': 'crossref', 'unstructured': 'Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño ' 'M, et al. Daily tenofovir disoproxil fumarate/emtricitabine and ' 'hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a ' 'double-blind placebo controlled randomized trial in healthcare workers. ' 'medRxiv. 2022:2022.03.02.22271710.', 'DOI': '10.1101/2022.03.02.22271710'}, { 'issue': '2', 'key': '891_CR25', 'doi-asserted-by': 'publisher', 'first-page': 'e0261980', 'DOI': '10.1371/journal.pone.0261980', 'volume': '17', 'author': 'J Rojas-Serrano', 'year': '2022', 'unstructured': 'Rojas-Serrano J, Portillo-Vásquez AM, Thirion-Romero I, Vázquez-Pérez J, ' 'Mejía-Nepomuceno F, Ramírez-Venegas A, et al. Hydroxychloroquine for ' 'prophylaxis of COVID-19 in health workers: A randomized clinical trial. ' 'PLoS ONE. 2022;17(2):e0261980.', 'journal-title': 'PLoS ONE'}, { 'key': '891_CR26', 'unstructured': 'Barnabas RV, Brown ER, Bershteyn A, Stankiewicz Karita HC, Johnston C, ' 'Thorpe LE, et al. Hydroxychloroquine as Postexposure Prophylaxis to ' 'Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A ' 'Randomized Trial. Ann Intern Med. 2020.'}, { 'key': '891_CR27', 'doi-asserted-by': 'publisher', 'first-page': '167', 'DOI': '10.1016/j.ijid.2021.12.343', 'volume': '116', 'author': 'JE McKinnon', 'year': '2022', 'unstructured': 'McKinnon JE, Wang DD, Zervos M, Saval M, Marshall-Nightengale L, Kilgore ' 'P, et al. Safety and tolerability of hydroxychloroquine in health care ' 'workers and first responders for the prevention of COVID-19: WHIP ' 'COVID-19 Study. Int J Infect Dis. 2022;116:167–73.', 'journal-title': 'Int J Infect Dis'}, { 'key': '891_CR28', 'unstructured': 'Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, et ' 'al. Updated U.S. Public Health Service guidelines for the management of ' 'occupational exposures to HIV and recommendations for postexposure ' 'prophylaxis.'}, { 'issue': '2', 'key': '891_CR29', 'first-page': '121.e1-15', 'volume': '34', 'author': '[Consensus Document on post-exposure prophylaxis against HIV', 'year': '2016', 'unstructured': '[Consensus Document on post-exposure prophylaxis against HIV. HBV and ' 'HCV in adults and children]. Enferm Infecc Microbiol Clin. ' '2016;34(2):121.e1-15.', 'journal-title': 'Enferm Infecc Microbiol Clin'}, { 'issue': '15', 'key': '891_CR30', 'doi-asserted-by': 'publisher', 'first-page': '732', 'DOI': '10.1093/cid/ciaa237', 'volume': '71', 'author': 'X Yao', 'year': '2020', 'unstructured': 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral ' 'Activity and Projection of Optimized Dosing Design of Hydroxychloroquine ' 'for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 ' '(SARS-CoV-2). Clin Infect diseases: official publication Infect Dis Soc ' 'Am. 2020;71(15):732–9.', 'journal-title': 'Clin Infect diseases: official publication Infect Dis Soc Am'}, { 'issue': '14', 'key': '891_CR31', 'doi-asserted-by': 'publisher', 'first-page': '1391', 'DOI': '10.1056/NEJMsm1605385', 'volume': '377', 'author': 'MA Hernan', 'year': '2017', 'unstructured': 'Hernan MA, Robins JM. Per-protocol analyses of pragmatic trials. N Engl ' 'J Med. 2017;377(14):1391–8.', 'journal-title': 'N Engl J Med'}, { 'key': '891_CR32', 'doi-asserted-by': 'crossref', 'unstructured': 'Dahabreh IJ, Petito LC, Robertson SE, Hernán MA, Steingrimsson JA. ' 'Toward Causally Interpretable Meta-analysis: Transporting Inferences ' 'from Multiple Randomized Trials to a New Target Population. Epidemiology ' '(Cambridge, Mass). 2020;31(3):334 – 44.', 'DOI': '10.1097/EDE.0000000000001177'}, { 'issue': '1', 'key': '891_CR33', 'doi-asserted-by': 'publisher', 'first-page': '475', 'DOI': '10.1186/s13063-020-04446-4', 'volume': '21', 'author': 'RV Barnabas', 'year': '2020', 'unstructured': 'Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, et al. ' 'Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent ' 'severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ' 'among adults exposed to coronavirus disease (COVID-19): a structured ' 'summary of a study protocol for a randomised controlled trial. Trials. ' '2020;21(1):475.', 'journal-title': 'Trials'}, { 'issue': '7748', 'key': '891_CR34', 'doi-asserted-by': 'publisher', 'first-page': '305', 'DOI': '10.1038/d41586-019-00857-9', 'volume': '567', 'author': 'V Amrhein', 'year': '2019', 'unstructured': 'Amrhein V, Greenland S, McShane B. Scientists rise up against ' 'statistical significance. Nature. 2019;567(7748):305–7.', 'journal-title': 'Nature'}, { 'issue': '4', 'key': '891_CR35', 'doi-asserted-by': 'publisher', 'first-page': '337', 'DOI': '10.1007/s10654-016-0149-3', 'volume': '31', 'author': 'S Greenland', 'year': '2016', 'unstructured': 'Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, et al. ' 'Statistical tests, P values, confidence intervals, and power: a guide to ' 'misinterpretations. Eur J Epidemiol. 2016;31(4):337–50.', 'journal-title': 'Eur J Epidemiol'}, { 'issue': '1', 'key': '891_CR36', 'doi-asserted-by': 'publisher', 'first-page': '2349', 'DOI': '10.1038/s41467-021-22446-z', 'volume': '12', 'author': 'C Axfors', 'year': '2021', 'unstructured': 'Axfors C, Schmitt AM, Janiaud P, van’t Hooft J, Abd-Elsalam S, Abdo EF, ' 'et al. Mortality outcomes with hydroxychloroquine and chloroquine in ' 'COVID-19 from an international collaborative meta-analysis of randomized ' 'trials. Nat Commun. 2021;12(1):2349.', 'journal-title': 'Nat Commun'}, { 'issue': '11', 'key': '891_CR37', 'doi-asserted-by': 'publisher', 'first-page': 'e20044', 'DOI': '10.2196/20044', 'volume': '22', 'author': 'K Niburski', 'year': '2020', 'unstructured': 'Niburski K, Niburski O. Impact of Trump’s Promotion of Unproven COVID-19 ' 'Treatments and Subsequent Internet Trends: Observational Study. J Med ' 'Internet Res. 2020;22(11):e20044.', 'journal-title': 'J Med Internet Res'}, { 'key': '891_CR38', 'first-page': 'n949-n', 'volume': '373', 'author': 'JJ Bartoszko', 'year': '2021', 'unstructured': 'Bartoszko JJ, Siemieniuk RAC, Kum E, Qasim A, Zeraatkar D, Ge L, et al. ' 'Prophylaxis against covid-19: living systematic review and network ' 'meta-analysis. BMJ (Clinical research ed). 2021;373:n949-n.', 'journal-title': 'BMJ (Clinical research ed)'}], 'container-title': 'European Journal of Epidemiology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s10654-022-00891-4.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s10654-022-00891-4/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s10654-022-00891-4.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 8, 9]], 'date-time': '2022-08-09T09:05:22Z', 'timestamp': 1660035922000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s10654-022-00891-4'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 8, 9]]}, 'references-count': 38, 'alternative-id': ['891'], 'URL': 'http://dx.doi.org/10.1007/s10654-022-00891-4', 'relation': {}, 'ISSN': ['0393-2990', '1573-7284'], 'subject': ['Epidemiology'], 'container-title-short': 'Eur J Epidemiol', 'published': {'date-parts': [[2022, 8, 9]]}, 'assertion': [ { 'value': '31 January 2022', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '16 June 2022', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '9 August 2022', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The authors have no relevant financial or non-financial interests to disclose.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing Interests'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}